VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Free Report) shares reached a new 52-week high during trading on Thursday. The stock traded as high as $118.03 and last traded at $116.6310, with a volume of 238,071 shares. The stock had previously closed at $115.58.
VanEck Pharmaceutical ETF Stock Performance
The business has a 50 day moving average price of $112.22 and a two-hundred day moving average price of $108.05. The company has a market cap of $1.17 billion, a P/E ratio of 20.21 and a beta of 0.45.
VanEck Pharmaceutical ETF Cuts Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, October 6th. Investors of record on Thursday, October 1st were given a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 1.2%. The ex-dividend date was Thursday, October 1st. This is a negative change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.6248.
Hedge Funds Weigh In On VanEck Pharmaceutical ETF
A number of large investors have recently bought and sold shares of the stock. WT Wealth Management lifted its position in VanEck Pharmaceutical ETF by 19.6% in the first quarter. WT Wealth Management now owns 50,384 shares of the company’s stock valued at $5,234,000 after purchasing an additional 8,252 shares during the last quarter. Fluent Financial LLC bought a new position in shares of VanEck Pharmaceutical ETF in the second quarter worth approximately $4,264,000. Independent Financial Group LLC bought a new position in shares of VanEck Pharmaceutical ETF in the first quarter worth approximately $532,000. Adamsbrown Wealth Consultants LLC increased its stake in shares of VanEck Pharmaceutical ETF by 3.6% in the second quarter. Adamsbrown Wealth Consultants LLC now owns 154,114 shares of the company’s stock worth $16,852,000 after buying an additional 5,303 shares during the period. Finally, Avior Wealth Management LLC purchased a new position in shares of VanEck Pharmaceutical ETF in the third quarter worth $1,685,000.
About VanEck Pharmaceutical ETF
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
See Also
- Five stocks we like better than VanEck Pharmaceutical ETF
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.
